ContraFect Layoffs
August 2022
ContraFect announced a layoff affecting 16 employees (37% of its workforce) in August 2022. The company operates in the Healthcare sector.
16
37%
Aug 15, 2022
About
ContraFect, a biotechnology company focused on infectious diseases, has implemented a workforce reduction following a significant setback in its clinical trial. The layoffs, announced on August 15, 2022, come as the company restructures its operations after its lead candidate, exebacase, failed to meet the primary endpoint in a Phase 3 study for Staphylococcus aureus bacteremia. While the exact number of employees affected was not disclosed, the cuts represent a strategic downsizing to preserve capital and extend the company's financial runway. This move is a common response in the volatile biotech industry when key clinical trials do not yield the desired results, forcing companies to re-evaluate their pipelines and operational scale.
More Healthcare Layoffs
Report an Error
If you find incorrect information, please let us know so we can correct it.
support@layoffs.nl